Institutional investors purchased a net $1.8 million shares of SCMP during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 41.08% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KRENSAVAGE ASSET MANAGEMENT LLC Bought 1.1 Million shares of Sucampo Pharmaceuticals I...